The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 338:1774-1775 June 11, 1998 Number 24
NextNext

Spinal and Epidural Hematoma and Low-Molecular-Weight Heparin

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: From May 1993 through February 1998, the Food and Drug Administration (FDA) received reports of 43 patients in the United States who had spinal or epidural hematoma or bleeding after receiving the low-molecular-weight heparin enoxaparin (Lovenox, Rhône–Poulenc Rorer Pharmaceuticals). Emergency decompressive laminectomy to evacuate the hematoma was performed in 28 patients, and permanent paraplegia, often with a delay in diagnosis or surgical treatment, occurred in 16.

Of the 37 patients whose sex was reported, 29 (78 percent) were women. The median age was 75 years (range, 28 to 90). Three persons had histories of ankylosing spondylitis or . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.